These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Digenzyme in the therapy of digestive insufficiency. Controlled clinical study]. Capria A; Marchioro M Minerva Gastroenterol; 1971; 17(2):84-91. PubMed ID: 5135989 [No Abstract] [Full Text] [Related]
44. [Studies on the effect of Cotazym forte in ambulatory patients]. Clemençon G Praxis; 1969 Apr; 58(13):415-8. PubMed ID: 5818667 [No Abstract] [Full Text] [Related]
45. [Double-blind study on the activity of RO 10-9618 (bromazepam and propantheline) in organic and functional disturbances of the gastrointestinal apparatus]. Destito D; Tentori-Montalto T Clin Ter; 1976 Jul; 78(1):57-63. PubMed ID: 12905 [No Abstract] [Full Text] [Related]
46. [Treatment of gastrointestinal diseases by a combination gefarnate-diazepam (Gefarnax)]. Finzi B; Giorgi-Conciato M; Peruzza M Minerva Gastroenterol; 1972; 18(4):214-26. PubMed ID: 4614117 [No Abstract] [Full Text] [Related]
47. [Clinical experiences with preparation Hylakombun in gastroenterology]. Kocián J; Kociánová J Wien Med Wochenschr Suppl; 1975 Mar; 25():1-8. PubMed ID: 1096477 [No Abstract] [Full Text] [Related]
48. [Treatment of some functional disorders of the digestive system: clinical experimentation with comparison of a medazepam-metoclopramide combination with medazepam-anticholinergic agent combination]. Natale L Clin Ter; 1975 Jan; 72(2):141-57. PubMed ID: 3308 [No Abstract] [Full Text] [Related]
49. [Clinical use of prifinium bromide: a new spasmolytic agent]. Marini U; Spotti D; Visconti P Clin Ter; 1978 Nov; 87(4):367-74. PubMed ID: 36254 [No Abstract] [Full Text] [Related]
51. [Development of a new digestive preparation from biological aspects]. Ehrhardt L; Hartmann V; Patt L Med Welt; 1973 Jan; 24(2):45-53. PubMed ID: 4803292 [No Abstract] [Full Text] [Related]
52. [Personal experience with the treatment of dyspeptic syndrome with a new drug combination]. Di Vittorio G; Santelli G Clin Ter; 1978 Feb; 84(4):425-32. PubMed ID: 648099 [No Abstract] [Full Text] [Related]
53. [Therapeutic experiences with a new preparation against digestive disorders]. Filser L Med Monatsschr; 1973 Apr; 27(4):181-2. PubMed ID: 4709327 [No Abstract] [Full Text] [Related]
54. [On the action of new spasmolytic-anxiolytic association in functional and organic gastrointestinal diseases]. Palmas F; Rossini FP; Bonardi L Minerva Gastroenterol; 1971; 17(2):73-83. PubMed ID: 5135988 [No Abstract] [Full Text] [Related]
56. [Current treatment of dyspeptic syndromes with a modern drug association evaluated with a double-blind study]. Mancini V; Pederzoli P Clin Ter; 1982 Apr; 101(1):71-4. PubMed ID: 6177468 [No Abstract] [Full Text] [Related]
57. [Clinical evaluation of Mexase]. Florkiewicz H Pol Tyg Lek; 1970 Aug; 25(31):1178-9. PubMed ID: 4248516 [No Abstract] [Full Text] [Related]
58. [Report on the clinical testing of Cormelian-Digotab]. Pollter J Med Welt; 1974 Nov; 25(48):2015-21. PubMed ID: 4617836 [No Abstract] [Full Text] [Related]
59. [Controlled clinical study of a new combination of a tranquilizer and an anticholinergic drug in various gastrointestinal diseases]. Maccà F; Caregaro L; Lauro S Minerva Dietol Gastroenterol; 1979; 25(1):33-40. PubMed ID: 36577 [No Abstract] [Full Text] [Related]
60. [Treatment with Hepavis, a new cholerectically-active hepaticum. Experiences from an internal medicine profemoral practice]. Stuchlik S Med Monatsschr; 1977 Nov; 31(11):524-6. PubMed ID: 927326 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]